In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

ESC Clinical Practice Guidelines

30 Aug 2021

The present guidelines have been developed to support healthcare professionals in their efforts to reduce the burden of ASCVD in both individual patients, as well as at a population level. The previous European Guidelines on CVD prevention in clinical practice were published in 2016. Recent developments in prediction of cardiovascular disease risk and treatment benefit, as well as novel treatments and treatment goals, necessitated new, up-to-date guidelines. The current guidelines on CVD prevention in clinical practice concentrate principally but not exclusively on the risk factors, risk classification, and prevention of ASCVD. The current guidelines provide recommendations on ASCVD prevention to support shared decision-making by the patient and their healthcare professional based on individual patient characteristics. Special considerations have been given to differences in age, sex and gender, life expectancy, risk factor profiles, ethnic, and geographic differences. 

Guidelines and related materials are for use by individuals for personal or educational purposes. No commercial use is allowed. Re-use permission must be correctly obtained from the publisher.

ESC Guidelines are protected by copyright. As per opt out option under Article 4 §3 of EU Directive 2019/790, the ESC reserves all rights to license uses of ESC Guidelines to train or develop generative artificial intelligence (AI) models, large language models or other deep learning or machine learning models. Any use of ESC Guidelines in software tools, generative AI models, computational models, or algorithms in which ESC Guideline content is included, cited, or transformed in any way requires a formal license agreement.

Stress, Psycho-Social and Cultural Aspects of Heart Disease
Hypertension
Nutrition, Malnutrition and Heart Disease
Tobacco
Risk Factors and Prevention
Physical Inactivity and Exercise
Obesity
Prevention
Cardiovascular Disease in the Elderly
Depression and Heart Disease

Endorsed by cardiac societies

Association of Cardiologists of Kazakhstan , French Society of Cardiology , Austrian Society of Cardiology , Azerbaijan Society of Cardiology , Belgian Society of Cardiology , Association of Cardiologists of Bosnia & Herzegovina , British Cardiovascular Society , Bulgarian Society of Cardiology , Croatian Cardiac Society , Cyprus Society of Cardiology , Czech Society of Cardiology , Danish Society of Cardiology , Egyptian Society of Cardiology , Estonian Society of Cardiology , Finnish Cardiac Society , German Cardiac Society , Hellenic Society of Cardiology , Hungarian Society of Cardiology , Italian Federation of Cardiology , Kyrgyz Society of Cardiology , Latvian Society of Cardiology , Luxembourg Society of Cardiology , Maltese Cardiac Society , National Society of Cardiology of North Macedonia , Norwegian Society of Cardiology , Polish Cardiac Society , Portuguese Society of Cardiology , Romanian Society of Cardiology , Russian Society of Cardiology* , San Marino Society of Cardiology , Cardiology Society of Serbia , Slovak Society of Cardiology , Spanish Society of Cardiology , Swiss Society of Cardiology , Tunisian Society of Cardiology and Cardiovascular Surgery , Turkish Society of Cardiology
About the ESC
Press and Media
Information
Follow us

         

 Need help?

 Help centre
 Contact us

© 2025 European Society of Cardiology. All rights reserved.